Yale COVID Study: Over One-Third of People With COVID-19 Develop Long COVID by Jacob Teitelbaum
Note: 30Seconds is a participant in affiliate advertising programs and this post may contain affiliate links, which means we may earn a commission or fees if you make a purchase via those links.
A meta-analysis of 429 studies published from 2021 to 2024 estimated a pooled global long COVID prevalence of 35 percent in COVID-19 positive individuals. The findings, titled Global Prevalence of Long COVID, its Subtypes and Risk Factors: An Updated Systematic Review and Meta-Analysis, were posted by the Yale School of Public Health on January 6, 2025, drawing on biostatistics from multiple departments at Yale and from the University of Michigan and Columbia University.
The study showed the prevalence of eight major long COVID subtypes in COVID-19 positive individuals: 20% (respiratory), 20% (general fatigue), 18% (psychological), 16% (neurological), 12% (dermatological), 10% (cardiovascular), 9% (musculoskeletal) and 5% (gastrointestinal). The most common symptom was memory problems, at 11%, meta-analyzed from 12 studies.
According to the authors, the research underscores “the need for accurate and standardized diagnostic tests and biomarkers for long COVID, a better understanding of the physiology of the condition, its treatment, and its potential effect on health care needs and workforce participation.”
Their conclusion is technically correct. But the public health emergency we’re facing requires radical, immediate measures that exceed standard procedures and pacing for research and treatment. Rome is burning, and we don’t have the luxury of time. We need an out-of-the-box effort similar to Operation Warp Speed, which created an unprecedented collaboration between the private sector and government to deliver vaccinations for COVID-19 nationwide in record time.
The inability to effectively test, diagnose and treat the smaller scale public health crisis of chronic fatigue syndrome (CFS) over many decades as an example of a public health failure to be avoided at all costs. While public health institutions are proud of the work they’ve done, most people with CFS are still suffering from chronic symptoms that seriously compromise their quality of life. Likewise, post-acute infection syndromes accompanying SARS, H1N1, MERS, and Epstein-Barr, have not been adequately addressed either.
Long COVID may sound benign, but it’s not, especially if it robs you of the ability to make a living and enjoy a normal life.
As of December 8, 2024, more than 777 million COVID-19 cases and seven million deaths have been documented worldwide. According to Nature, long COVID results in an annual global economic cost of $1 trillion, equivalent to 1 percent of the world economy.
Note: The content on 30Seconds.com is for informational and entertainment purposes only, and should not be considered medical advice. The information on this site should not be used to diagnose or treat a health problem or disease, and is not a substitute for professional care. Always consult your personal healthcare provider. The opinions or views expressed on 30Seconds.com do not necessarily represent those of 30Seconds or any of its employees, corporate partners or affiliates.
Take 30 seconds and join the 30Seconds community, and follow us on Facebook to get inspiration in your newsfeed daily. Food, fun, health, happiness.
30Second Mobile, Inc. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.
Related Products on Amazon We Think You May Like:
The study showed the prevalence of eight major long COVID subtypes in COVID-19 positive individuals: 20% (respiratory), 20% (general fatigue), 18% (psychological), 16% (neurological), 12% (dermatological), 10% (cardiovascular), 9% (musculoskeletal) and 5% (gastrointestinal). The most common symptom was memory problems, at 11%, meta-analyzed from 12 studies.